Gene Symbol | Gene ID | Gene Info |
---|---|---|
Isl2
|
ENSMUSG00000032318.6 | insulin related protein 2 (islet 2) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_55541247_55541403 | Isl2 | 118 | 0.821191 | 0.63 | 2.0e-07 | Click! |
chr9_55542292_55542443 | Isl2 | 31 | 0.959878 | 0.56 | 8.7e-06 | Click! |
chr9_55546260_55546445 | Isl2 | 4016 | 0.172821 | 0.01 | 9.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_71507941_71508418 | 13.25 |
1700112M02Rik |
RIKEN cDNA 1700112M02 gene |
20572 |
0.26 |
chr16_63806441_63806811 | 11.72 |
Epha3 |
Eph receptor A3 |
56787 |
0.15 |
chr8_61515184_61515647 | 11.17 |
Palld |
palladin, cytoskeletal associated protein |
485 |
0.84 |
chr18_20621651_20622570 | 10.99 |
Gm16090 |
predicted gene 16090 |
43150 |
0.11 |
chr16_63747767_63748162 | 10.60 |
Gm22769 |
predicted gene, 22769 |
430 |
0.91 |
chr12_33035439_33035619 | 10.48 |
Cdhr3 |
cadherin-related family member 3 |
17457 |
0.14 |
chrX_166344291_166344543 | 9.80 |
Gpm6b |
glycoprotein m6b |
275 |
0.93 |
chr12_29526481_29526772 | 9.61 |
Myt1l |
myelin transcription factor 1-like |
1758 |
0.41 |
chr9_99994460_99994673 | 8.45 |
4930519F24Rik |
RIKEN cDNA 4930519F24 gene |
27734 |
0.17 |
chr3_78792451_78792970 | 8.43 |
Gm18952 |
predicted gene, 18952 |
34091 |
0.19 |
chr5_111195506_111196004 | 8.42 |
Gm43676 |
predicted gene 43676 |
1385 |
0.43 |
chr16_28851391_28851583 | 8.05 |
Mb21d2 |
Mab-21 domain containing 2 |
15120 |
0.27 |
chr16_85092305_85093056 | 7.95 |
Gm49227 |
predicted gene, 49227 |
12569 |
0.2 |
chr1_81594178_81594459 | 7.88 |
Gm6198 |
predicted gene 6198 |
36835 |
0.2 |
chr1_20905491_20905707 | 7.78 |
Gm24171 |
predicted gene, 24171 |
9941 |
0.12 |
chr3_127294086_127294512 | 7.19 |
Gm42970 |
predicted gene 42970 |
5374 |
0.15 |
chr14_59737148_59737645 | 7.13 |
Gm19716 |
predicted gene, 19716 |
94848 |
0.07 |
chr1_53740102_53740664 | 7.06 |
Stk17b |
serine/threonine kinase 17b (apoptosis-inducing) |
22310 |
0.18 |
chr1_127531215_127531971 | 6.98 |
Tmem163 |
transmembrane protein 163 |
5837 |
0.29 |
chr14_31934365_31934741 | 6.97 |
D830044D21Rik |
RIKEN cDNA D830044D21 gene |
28025 |
0.16 |
chr12_56458764_56459233 | 6.94 |
Sfta3-ps |
surfactant associated 3, pseudogene |
34326 |
0.12 |
chr8_25392912_25393353 | 6.92 |
Gm39147 |
predicted gene, 39147 |
5888 |
0.16 |
chr10_67560099_67560286 | 6.82 |
4930563J15Rik |
RIKEN cDNA 4930563J15 gene |
9846 |
0.12 |
chr19_20923632_20923852 | 6.80 |
Gm32750 |
predicted gene, 32750 |
1350 |
0.52 |
chr1_96346717_96347057 | 6.79 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chr13_44100199_44100380 | 6.72 |
Gm33630 |
predicted gene, 33630 |
329 |
0.89 |
chr9_92930312_92930463 | 6.64 |
Gm28054 |
predicted gene 28054 |
34555 |
0.17 |
chr10_125839935_125840086 | 6.63 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
126158 |
0.06 |
chr16_89538151_89538450 | 6.60 |
Krtap7-1 |
keratin associated protein 7-1 |
29977 |
0.13 |
chr9_9263661_9263812 | 6.60 |
Gm16833 |
predicted gene, 16833 |
3053 |
0.29 |
chr2_3420278_3420597 | 6.57 |
Meig1 |
meiosis expressed gene 1 |
1308 |
0.32 |
chr14_123513463_123513659 | 6.56 |
Nalcn |
sodium leak channel, non-selective |
113315 |
0.06 |
chr16_62686085_62686411 | 6.55 |
Gm9816 |
predicted pseudogene 9816 |
30789 |
0.18 |
chr12_33225361_33225571 | 6.54 |
Atxn7l1os1 |
ataxin 7-like 1, opposite strand 1 |
3388 |
0.28 |
chrX_84076768_84076943 | 6.53 |
Dmd |
dystrophin, muscular dystrophy |
206 |
0.96 |
chr5_82966151_82966304 | 6.45 |
Gm43217 |
predicted gene 43217 |
74777 |
0.12 |
chr4_104270276_104270441 | 6.43 |
Dab1 |
disabled 1 |
96755 |
0.09 |
chr3_66325480_66326023 | 6.39 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
28914 |
0.18 |
chr14_35112923_35113111 | 6.34 |
Gm49034 |
predicted gene, 49034 |
106421 |
0.07 |
chr18_89564398_89564718 | 6.30 |
Dok6 |
docking protein 6 |
4489 |
0.24 |
chr2_102128585_102128775 | 6.28 |
Ldlrad3 |
low density lipoprotein receptor class A domain containing 3 |
9439 |
0.21 |
chr4_99574046_99574523 | 6.27 |
Gm12690 |
predicted gene 12690 |
4784 |
0.18 |
chr14_5071425_5071784 | 6.24 |
Gm8281 |
predicted gene, 8281 |
564 |
0.68 |
chr10_51015016_51015208 | 6.21 |
Sim1 |
single-minded family bHLH transcription factor 1 |
119461 |
0.06 |
chr8_34326259_34326892 | 6.19 |
Gm4889 |
predicted gene 4889 |
1335 |
0.32 |
chr5_9339805_9340127 | 6.16 |
Gm15733 |
predicted gene 15733 |
13793 |
0.19 |
chr1_150949983_150950458 | 6.14 |
Hmcn1 |
hemicentin 1 |
42831 |
0.14 |
chr18_48073886_48074054 | 6.12 |
Gm5237 |
predicted gene 5237 |
3948 |
0.29 |
chr19_14436131_14436458 | 6.09 |
Tle4 |
transducin-like enhancer of split 4 |
159245 |
0.04 |
chr13_83736071_83736420 | 6.06 |
Gm33366 |
predicted gene, 33366 |
2290 |
0.18 |
chr3_26641406_26641733 | 6.05 |
Spata16 |
spermatogenesis associated 16 |
3919 |
0.29 |
chr13_99459018_99459548 | 6.04 |
Map1b |
microtubule-associated protein 1B |
11663 |
0.18 |
chr15_67898912_67899432 | 6.02 |
Gm49408 |
predicted gene, 49408 |
25344 |
0.23 |
chr1_30061154_30061322 | 6.02 |
Gm23771 |
predicted gene, 23771 |
75304 |
0.12 |
chr6_22984216_22984575 | 6.01 |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
1914 |
0.44 |
chr18_55506946_55507169 | 5.95 |
Gm37337 |
predicted gene, 37337 |
10057 |
0.3 |
chr17_66869624_66870037 | 5.95 |
Gm49940 |
predicted gene, 49940 |
7590 |
0.18 |
chr2_106512677_106513062 | 5.95 |
Gm14015 |
predicted gene 14015 |
10234 |
0.26 |
chr4_72384628_72385513 | 5.94 |
Gm11235 |
predicted gene 11235 |
157596 |
0.04 |
chr13_90722692_90722897 | 5.92 |
Gm44338 |
predicted gene, 44338 |
37318 |
0.17 |
chr2_132427639_132427949 | 5.91 |
4921508D12Rik |
RIKEN cDNA 4921508D12 gene |
3053 |
0.25 |
chr14_79203440_79203814 | 5.89 |
Gm4632 |
predicted gene 4632 |
4437 |
0.18 |
chr3_114380029_114380180 | 5.89 |
Gm43749 |
predicted gene 43749 |
164668 |
0.04 |
chr2_126932364_126933545 | 5.87 |
Sppl2a |
signal peptide peptidase like 2A |
281 |
0.9 |
chr1_42540124_42540492 | 5.85 |
Gm37047 |
predicted gene, 37047 |
48495 |
0.15 |
chr10_18360177_18360562 | 5.82 |
Gm18942 |
predicted gene, 18942 |
23128 |
0.17 |
chr5_30525916_30526077 | 5.81 |
Gm42765 |
predicted gene 42765 |
3461 |
0.17 |
chr14_48709709_48710071 | 5.80 |
Gm49153 |
predicted gene, 49153 |
5706 |
0.11 |
chr3_62454253_62454452 | 5.79 |
Dhx36 |
DEAH (Asp-Glu-Ala-His) box polypeptide 36 |
18235 |
0.22 |
chr8_48509354_48509578 | 5.78 |
Tenm3 |
teneurin transmembrane protein 3 |
45847 |
0.19 |
chr14_3572445_3572748 | 5.78 |
Gm3005 |
predicted gene 3005 |
573 |
0.69 |
chr13_44043304_44043584 | 5.73 |
Gm33489 |
predicted gene, 33489 |
24922 |
0.17 |
chr14_24550971_24551440 | 5.71 |
Rps24 |
ribosomal protein S24 |
60056 |
0.09 |
chr13_99842476_99842627 | 5.69 |
Cartpt |
CART prepropeptide |
58090 |
0.13 |
chr16_63278367_63278696 | 5.69 |
Gm33912 |
predicted gene, 33912 |
61089 |
0.15 |
chr1_42693315_42693672 | 5.69 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
340 |
0.76 |
chr13_31408869_31409060 | 5.69 |
G630018N14Rik |
RIKEN cDNA G630018N14 gene |
42 |
0.97 |
chr5_99062665_99062987 | 5.65 |
Prkg2 |
protein kinase, cGMP-dependent, type II |
25475 |
0.2 |
chr2_109678555_109678726 | 5.64 |
Bdnf |
brain derived neurotrophic factor |
1608 |
0.32 |
chr7_51784054_51784235 | 5.64 |
Gm29296 |
predicted gene 29296 |
11418 |
0.17 |
chr13_83739197_83739995 | 5.64 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
733 |
0.33 |
chr8_103314608_103315058 | 5.59 |
1600027J07Rik |
RIKEN cDNA 1600027J07 gene |
32701 |
0.2 |
chr10_43106136_43106524 | 5.57 |
Gm29245 |
predicted gene 29245 |
47886 |
0.11 |
chr10_25112532_25112706 | 5.57 |
Gm22566 |
predicted gene, 22566 |
58479 |
0.1 |
chr3_3831527_3831694 | 5.55 |
Gm2071 |
predicted gene 2071 |
2326 |
0.38 |
chr7_64884497_64884825 | 5.55 |
Nsmce3 |
NSE3 homolog, SMC5-SMC6 complex component |
11664 |
0.22 |
chr3_45385015_45385410 | 5.55 |
Pcdh10 |
protocadherin 10 |
2579 |
0.24 |
chr6_73644786_73645257 | 5.54 |
Gm31747 |
predicted gene, 31747 |
36348 |
0.2 |
chr5_66918045_66918260 | 5.53 |
Gm43281 |
predicted gene 43281 |
2144 |
0.26 |
chr9_41378019_41378386 | 5.51 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1641 |
0.36 |
chr6_111293807_111293981 | 5.49 |
Grm7 |
glutamate receptor, metabotropic 7 |
201821 |
0.03 |
chr1_167082821_167083037 | 5.46 |
Gm17868 |
predicted gene, 17868 |
58226 |
0.11 |
chr8_108454991_108455142 | 5.44 |
Gm39244 |
predicted gene, 39244 |
81881 |
0.1 |
chr2_105334055_105334237 | 5.44 |
Rcn1 |
reticulocalbin 1 |
61202 |
0.12 |
chr6_93792884_93793099 | 5.37 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
452 |
0.66 |
chr4_54371542_54371700 | 5.37 |
Gm12469 |
predicted gene 12469 |
135745 |
0.05 |
chr9_74925390_74925925 | 5.36 |
Fam214a |
family with sequence similarity 214, member A |
27227 |
0.15 |
chr13_107767262_107767617 | 5.35 |
Zswim6 |
zinc finger SWIM-type containing 6 |
19157 |
0.22 |
chr3_141936313_141936536 | 5.35 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
4901 |
0.33 |
chr4_153224509_153224948 | 5.32 |
Gm13174 |
predicted gene 13174 |
6552 |
0.3 |
chr14_5387971_5388348 | 5.30 |
Gm3500 |
predicted gene 3500 |
890 |
0.46 |
chr4_120170416_120170874 | 5.29 |
Edn2 |
endothelin 2 |
9439 |
0.24 |
chr4_22095654_22096002 | 5.29 |
Gm11880 |
predicted gene 11880 |
21704 |
0.23 |
chr10_26328033_26328184 | 5.28 |
L3mbtl3 |
L3MBTL3 histone methyl-lysine binding protein |
11834 |
0.17 |
chr4_72382387_72382548 | 5.27 |
Gm11235 |
predicted gene 11235 |
160199 |
0.04 |
chr3_42111396_42111547 | 5.25 |
Gm37846 |
predicted gene, 37846 |
52394 |
0.16 |
chr3_139885937_139886924 | 5.24 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr5_4811967_4812118 | 5.23 |
Gm44483 |
predicted gene, 44483 |
9585 |
0.12 |
chr4_71229701_71230138 | 5.22 |
Gm11229 |
predicted gene 11229 |
56023 |
0.15 |
chr8_31895464_31895660 | 5.22 |
Nrg1 |
neuregulin 1 |
8976 |
0.25 |
chr19_18888764_18889099 | 5.21 |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
48294 |
0.16 |
chr14_75235954_75236330 | 5.20 |
Cpb2 |
carboxypeptidase B2 (plasma) |
6145 |
0.15 |
chr15_103519338_103519794 | 5.20 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
4152 |
0.16 |
chr13_78427126_78427725 | 5.19 |
Gm31946 |
predicted gene, 31946 |
177 |
0.95 |
chr2_49815790_49816032 | 5.18 |
Gm13480 |
predicted gene 13480 |
2963 |
0.3 |
chr10_33624726_33624916 | 5.17 |
Clvs2 |
clavesin 2 |
52 |
0.9 |
chr1_64409346_64409511 | 5.16 |
Gm25748 |
predicted gene, 25748 |
13094 |
0.22 |
chr3_130738031_130738217 | 5.16 |
Gm42997 |
predicted gene 42997 |
7523 |
0.12 |
chr5_24490371_24490585 | 5.15 |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
10306 |
0.09 |
chr13_17993545_17993782 | 5.15 |
Yae1d1 |
Yae1 domain containing 1 |
314 |
0.75 |
chr18_20616739_20617639 | 5.14 |
Gm16090 |
predicted gene 16090 |
48071 |
0.1 |
chr15_13392917_13393530 | 5.14 |
Gm8238 |
predicted gene 8238 |
25633 |
0.22 |
chr9_122635277_122635496 | 5.14 |
Gm47134 |
predicted gene, 47134 |
12444 |
0.13 |
chr2_82052991_82053222 | 5.10 |
Zfp804a |
zinc finger protein 804A |
116 |
0.98 |
chr6_12117902_12118084 | 5.09 |
Gm6578 |
predicted gene 6578 |
8410 |
0.23 |
chr2_162282305_162282495 | 5.08 |
Ptprtos |
protein tyrosine phosphatase, receptor type T, opposite strand |
108413 |
0.07 |
chr5_111893672_111894498 | 5.07 |
Gm42488 |
predicted gene 42488 |
50150 |
0.15 |
chr14_5502289_5502728 | 5.07 |
Gm3488 |
predicted gene, 3488 |
834 |
0.47 |
chr5_4651240_4651409 | 5.06 |
Fzd1 |
frizzled class receptor 1 |
106711 |
0.06 |
chr6_30580402_30580603 | 5.06 |
Gm13781 |
predicted gene 13781 |
4467 |
0.14 |
chr13_84064676_84065083 | 5.06 |
Gm17750 |
predicted gene, 17750 |
107 |
0.97 |
chr2_18731674_18731995 | 5.05 |
Gm13333 |
predicted gene 13333 |
27150 |
0.12 |
chr4_72168337_72168543 | 5.03 |
Gm11250 |
predicted gene 11250 |
328 |
0.91 |
chr4_9011132_9011567 | 5.03 |
Rps18-ps2 |
ribosomal protein S18, pseudogene 2 |
70090 |
0.13 |
chr17_9543267_9543689 | 5.02 |
Gm49807 |
predicted gene, 49807 |
6213 |
0.28 |
chr18_55547563_55547746 | 5.01 |
Gm37337 |
predicted gene, 37337 |
30540 |
0.24 |
chr2_51087621_51088075 | 5.01 |
Rnd3 |
Rho family GTPase 3 |
61246 |
0.13 |
chr14_3333318_3333683 | 5.01 |
Gm2956 |
predicted gene 2956 |
873 |
0.51 |
chr13_15759168_15760299 | 5.01 |
Gm48408 |
predicted gene, 48408 |
10387 |
0.18 |
chr9_90693038_90693253 | 5.00 |
Gm2497 |
predicted gene 2497 |
40379 |
0.14 |
chr14_3049596_3050027 | 5.00 |
Gm2897 |
predicted gene 2897 |
526 |
0.7 |
chr16_23258903_23259100 | 5.00 |
St6gal1 |
beta galactoside alpha 2,6 sialyltransferase 1 |
10628 |
0.14 |
chr4_75856061_75856229 | 4.99 |
Gm11256 |
predicted gene 11256 |
1627 |
0.5 |
chr8_4206127_4207837 | 4.95 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr3_40673604_40673797 | 4.94 |
Intu |
inturned planar cell polarity protein |
1079 |
0.49 |
chr4_32189105_32189411 | 4.94 |
Gm11929 |
predicted gene 11929 |
17890 |
0.19 |
chr2_144127511_144127732 | 4.94 |
Gm11687 |
predicted gene 11687 |
15752 |
0.16 |
chr2_14823795_14824119 | 4.93 |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
69 |
0.97 |
chr1_18758436_18758855 | 4.92 |
Gm5252 |
predicted gene 5252 |
50217 |
0.18 |
chr10_98258415_98258598 | 4.91 |
Gm48687 |
predicted gene, 48687 |
42513 |
0.19 |
chr8_6132218_6132692 | 4.91 |
Gm44842 |
predicted gene 44842 |
86213 |
0.09 |
chr1_131351910_131352118 | 4.91 |
Srgap2 |
SLIT-ROBO Rho GTPase activating protein 2 |
7467 |
0.14 |
chr19_59394106_59394400 | 4.91 |
Gm33756 |
predicted gene, 33756 |
4469 |
0.19 |
chr11_88240584_88240997 | 4.91 |
Gm38534 |
predicted gene, 38534 |
12578 |
0.16 |
chr18_69499847_69500007 | 4.91 |
Tcf4 |
transcription factor 4 |
538 |
0.85 |
chr14_4183274_4183610 | 4.89 |
Gm2974 |
predicted gene 2974 |
866 |
0.5 |
chr14_7567758_7569131 | 4.89 |
Gm3558 |
predicted gene 3558 |
122 |
0.95 |
chr18_10735661_10735836 | 4.88 |
Mib1 |
mindbomb E3 ubiquitin protein ligase 1 |
9224 |
0.12 |
chr5_147155422_147155776 | 4.85 |
Gsx1 |
GS homeobox 1 |
33097 |
0.12 |
chr13_104519090_104519355 | 4.84 |
2610204G07Rik |
RIKEN cDNA 2610204G07 gene |
165709 |
0.03 |
chr4_24429061_24429567 | 4.84 |
Gm27243 |
predicted gene 27243 |
1576 |
0.43 |
chr8_26999303_26999520 | 4.84 |
Gm45370 |
predicted gene 45370 |
3161 |
0.13 |
chr15_65593099_65593523 | 4.82 |
Gm49243 |
predicted gene, 49243 |
94837 |
0.08 |
chr3_34331071_34331263 | 4.82 |
Gm38505 |
predicted gene, 38505 |
20545 |
0.21 |
chr13_68601300_68601505 | 4.81 |
1700001L19Rik |
RIKEN cDNA 1700001L19 gene |
3963 |
0.19 |
chr15_56077837_56078000 | 4.81 |
Gm49212 |
predicted gene, 49212 |
28086 |
0.19 |
chr15_99605686_99605837 | 4.76 |
Aqp6 |
aquaporin 6 |
4361 |
0.12 |
chr14_4415827_4416278 | 4.76 |
Gm3164 |
predicted gene 3164 |
604 |
0.63 |
chr3_5389410_5389753 | 4.74 |
4930555M17Rik |
RIKEN cDNA 4930555M17 gene |
125752 |
0.05 |
chr19_7172665_7172855 | 4.73 |
Otub1 |
OTU domain, ubiquitin aldehyde binding 1 |
27704 |
0.11 |
chr8_61325062_61325301 | 4.73 |
1700001D01Rik |
RIKEN cDNA 1700001D01 gene |
36309 |
0.13 |
chr14_5960610_5960983 | 4.72 |
Gm3248 |
predicted gene 3248 |
949 |
0.39 |
chr10_115572247_115572421 | 4.72 |
A930009A15Rik |
RIKEN cDNA A930009A15 gene |
2348 |
0.3 |
chr4_91375497_91375712 | 4.71 |
Elavl2 |
ELAV like RNA binding protein 1 |
703 |
0.65 |
chr13_83744413_83744884 | 4.70 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5785 |
0.13 |
chr5_42068234_42068511 | 4.70 |
Gm16223 |
predicted gene 16223 |
412 |
0.91 |
chr6_112809545_112809826 | 4.69 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
19774 |
0.21 |
chr14_34536041_34536258 | 4.69 |
9230112D13Rik |
RIKEN cDNA 9230112D13 gene |
13348 |
0.12 |
chr5_65130986_65131181 | 4.68 |
Klhl5 |
kelch-like 5 |
7 |
0.97 |
chr6_24201035_24201450 | 4.67 |
Slc13a1 |
solute carrier family 13 (sodium/sulfate symporters), member 1 |
33150 |
0.18 |
chr11_80080470_80081713 | 4.67 |
Crlf3 |
cytokine receptor-like factor 3 |
100 |
0.96 |
chrX_130503063_130503289 | 4.65 |
Gm14987 |
predicted gene 14987 |
10613 |
0.22 |
chr2_114019902_114020097 | 4.65 |
A530058N18Rik |
RIKEN cDNA A530058N18 gene |
6254 |
0.17 |
chr5_64476669_64477265 | 4.64 |
C030018K13Rik |
RIKEN cDNA C030018K13 gene |
41 |
0.96 |
chr4_9124626_9124900 | 4.63 |
Gm23423 |
predicted gene, 23423 |
85240 |
0.1 |
chr1_74103754_74104304 | 4.62 |
Tns1 |
tensin 1 |
5353 |
0.18 |
chr12_92589210_92589401 | 4.62 |
Gm18500 |
predicted gene, 18500 |
115344 |
0.07 |
chr13_72298631_72298782 | 4.62 |
Gm4052 |
predicted gene 4052 |
51515 |
0.15 |
chr5_150894457_150894771 | 4.61 |
Gm43298 |
predicted gene 43298 |
11972 |
0.2 |
chr3_154817331_154817637 | 4.58 |
Gm18589 |
predicted gene, 18589 |
22123 |
0.2 |
chr6_16942491_16942642 | 4.58 |
Gm5721 |
predicted gene 5721 |
17335 |
0.22 |
chr18_47301577_47301755 | 4.56 |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
20471 |
0.21 |
chr4_71230174_71230407 | 4.55 |
Gm11229 |
predicted gene 11229 |
55652 |
0.15 |
chr3_134629851_134630075 | 4.54 |
Gm26820 |
predicted gene, 26820 |
802 |
0.76 |
chr1_138500251_138500631 | 4.53 |
Gm28501 |
predicted gene 28501 |
15174 |
0.2 |
chr3_79475048_79475264 | 4.52 |
Fnip2 |
folliculin interacting protein 2 |
8951 |
0.21 |
chr11_80312155_80312495 | 4.49 |
Rhbdl3 |
rhomboid like 3 |
7365 |
0.2 |
chr18_39078823_39079010 | 4.48 |
Arhgap26 |
Rho GTPase activating protein 26 |
20395 |
0.24 |
chr4_85250379_85250530 | 4.48 |
Gm12413 |
predicted gene 12413 |
4692 |
0.28 |
chr5_35454198_35454812 | 4.48 |
Gm43377 |
predicted gene 43377 |
58407 |
0.08 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
2.5 | 7.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
2.2 | 6.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.1 | 6.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.0 | 5.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.8 | 12.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.6 | 4.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.6 | 6.5 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.6 | 4.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.4 | 7.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.3 | 5.3 | GO:0007412 | axon target recognition(GO:0007412) |
1.3 | 5.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.3 | 7.8 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.3 | 3.9 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.3 | 3.8 | GO:0050975 | sensory perception of touch(GO:0050975) |
1.2 | 5.0 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.2 | 4.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.2 | 3.5 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.1 | 16.0 | GO:0003334 | keratinocyte development(GO:0003334) |
1.1 | 3.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.1 | 4.4 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.1 | 3.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.1 | 4.3 | GO:0060005 | vestibular reflex(GO:0060005) |
1.1 | 5.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.1 | 2.1 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
1.1 | 4.3 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
1.0 | 3.1 | GO:0007525 | somatic muscle development(GO:0007525) |
1.0 | 13.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.0 | 3.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.0 | 3.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.0 | 1.9 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.9 | 3.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.9 | 2.8 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.9 | 3.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.9 | 4.6 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.9 | 9.9 | GO:0060013 | righting reflex(GO:0060013) |
0.9 | 2.6 | GO:0030070 | insulin processing(GO:0030070) |
0.8 | 2.5 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.8 | 4.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.8 | 3.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.8 | 6.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.8 | 2.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.8 | 4.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.8 | 2.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.8 | 2.3 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.8 | 1.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.7 | 3.0 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.7 | 2.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.7 | 2.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.7 | 1.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.7 | 2.9 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.7 | 2.1 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.7 | 2.8 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.7 | 1.4 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.7 | 3.4 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.7 | 2.0 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.7 | 0.7 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.7 | 2.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.6 | 1.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 2.5 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.6 | 3.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.6 | 1.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 0.6 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.6 | 1.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 1.2 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.6 | 3.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.6 | 3.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.6 | 1.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.6 | 1.2 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.6 | 1.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.6 | 2.3 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.6 | 1.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.6 | 1.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.6 | 0.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.6 | 1.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.6 | 9.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.6 | 1.7 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.6 | 2.8 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.6 | 2.8 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.6 | 2.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.6 | 1.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.6 | 2.2 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.6 | 3.9 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.6 | 1.7 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.6 | 2.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.5 | 0.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.5 | 1.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.5 | 1.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.5 | 3.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 1.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.5 | 2.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 1.1 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.5 | 2.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.5 | 4.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.5 | 3.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.5 | 0.5 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 2.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 2.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.5 | 1.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 0.5 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.5 | 3.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.5 | 0.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.5 | 1.0 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.5 | 1.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.5 | 1.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.5 | 1.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.5 | 3.5 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 1.0 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.5 | 1.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 1.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.5 | 1.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.5 | 3.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.5 | 2.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.4 | 4.0 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.4 | 3.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.4 | 2.7 | GO:0071625 | vocalization behavior(GO:0071625) |
0.4 | 1.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 0.9 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.4 | 1.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.4 | 1.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 1.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.4 | 1.7 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.4 | 0.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.4 | 1.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 2.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.4 | 0.8 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 6.5 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.4 | 1.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 2.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.4 | 1.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.4 | 2.4 | GO:0060897 | neural plate regionalization(GO:0060897) |
0.4 | 0.4 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 1.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 1.2 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.4 | 3.1 | GO:0035878 | nail development(GO:0035878) |
0.4 | 1.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.4 | 0.8 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.4 | 1.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 2.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.4 | 0.4 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.4 | 1.5 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 1.9 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.4 | 0.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 3.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 1.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.4 | 1.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 1.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.4 | 1.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.4 | 1.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 1.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 1.4 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.4 | 0.7 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 0.4 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.4 | 0.7 | GO:0014029 | neural crest formation(GO:0014029) |
0.4 | 1.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 1.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 3.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 1.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 1.0 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 0.7 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.3 | 0.7 | GO:0072234 | metanephric nephron tubule development(GO:0072234) |
0.3 | 2.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 4.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.3 | 1.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 1.6 | GO:0021764 | amygdala development(GO:0021764) |
0.3 | 1.3 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.3 | 26.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 1.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.3 | 1.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 3.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 1.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 1.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 0.6 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.3 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 2.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 2.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 1.2 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.3 | 0.9 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 0.6 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.3 | 0.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 0.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 1.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 0.6 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.3 | 1.2 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 0.3 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.3 | 0.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 1.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 2.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 1.4 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.3 | 0.6 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 0.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 2.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 1.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 0.8 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.3 | 0.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 0.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 1.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.3 | 1.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.3 | 0.8 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 0.3 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.3 | 0.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.3 | 1.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 0.8 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.3 | 2.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 0.5 | GO:0048143 | astrocyte activation(GO:0048143) |
0.3 | 0.5 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.3 | 0.8 | GO:1901656 | glycoside transport(GO:1901656) |
0.3 | 0.5 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 1.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 1.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 1.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.5 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.2 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.7 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.2 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.2 | 3.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.9 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.5 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.9 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.9 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 1.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.7 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.7 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.2 | 0.7 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 0.9 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 0.9 | GO:0060539 | diaphragm development(GO:0060539) |
0.2 | 1.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.4 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.2 | 1.5 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 0.4 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.2 | 0.2 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 0.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 1.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 1.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.6 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 1.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.2 | 0.8 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 3.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.2 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.2 | 0.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 1.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 1.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.6 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 1.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.6 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.2 | 1.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.9 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 0.7 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.5 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.2 | 0.2 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 1.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 0.2 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.2 | 0.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 0.5 | GO:0060592 | mammary gland formation(GO:0060592) |
0.2 | 0.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.2 | 0.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.2 | 0.7 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.5 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 0.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 1.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.5 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 0.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.2 | 0.7 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.2 | 0.3 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.2 | 4.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.2 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.2 | 0.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 1.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.3 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.2 | 3.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.2 | 0.5 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.6 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.8 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 1.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.9 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 0.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.2 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 0.6 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 3.4 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 0.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.5 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 2.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 0.8 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 1.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.4 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.6 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 2.4 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.1 | 0.7 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.9 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.1 | GO:0072207 | metanephric epithelium development(GO:0072207) |
0.1 | 0.4 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.1 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.1 | 1.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.7 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.3 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.3 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.1 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 1.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 1.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.4 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.1 | 0.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.1 | 0.4 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.8 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.7 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 1.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.3 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.6 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.1 | 0.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.4 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.1 | 1.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 3.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.7 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.1 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.5 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.8 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.1 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.8 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.4 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 1.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 1.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.5 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.2 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 0.4 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.1 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.7 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 1.7 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 1.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 1.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 1.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.2 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.1 | 0.5 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 1.1 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.7 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.8 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) |
0.1 | 2.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.3 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.6 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.3 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.3 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.6 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.1 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.1 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.1 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.4 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 2.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.7 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.7 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.1 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.1 | 0.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 0.1 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 0.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.1 | 0.2 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.1 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.3 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.2 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.1 | 0.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.1 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.1 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 1.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0003207 | cardiac chamber formation(GO:0003207) |
0.1 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.7 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.1 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.4 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.1 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 0.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.2 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.2 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 2.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.8 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 1.4 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.2 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.1 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
0.1 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.4 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.1 | 0.3 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:0044533 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.1 | 0.4 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.1 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.1 | 0.4 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.2 | GO:0098868 | bone growth(GO:0098868) |
0.1 | 0.2 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.5 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 1.3 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.2 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.1 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.0 | 0.0 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.0 | 1.9 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.0 | 2.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.7 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.0 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.0 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.0 | GO:0060872 | semicircular canal development(GO:0060872) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.0 | GO:1902688 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.0 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.0 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
0.0 | 0.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.0 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.1 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.0 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.0 | 0.0 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.0 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.3 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.7 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.2 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.0 | 0.2 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.3 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.0 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.0 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.0 | 0.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.1 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.0 | 0.0 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.8 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.0 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.0 | 0.0 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.0 | 0.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.0 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.1 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.0 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 14.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.3 | 3.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.2 | 7.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.2 | 3.5 | GO:0072534 | perineuronal net(GO:0072534) |
1.1 | 3.4 | GO:0048179 | activin receptor complex(GO:0048179) |
1.1 | 7.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.0 | 6.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.0 | 7.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.9 | 4.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.8 | 9.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.8 | 2.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.8 | 4.6 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.7 | 2.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.7 | 7.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 2.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 18.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 2.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.6 | 2.8 | GO:0097433 | dense body(GO:0097433) |
0.5 | 8.2 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 0.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.5 | 2.1 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 5.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 0.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 3.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 1.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 18.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 4.9 | GO:0043196 | varicosity(GO:0043196) |
0.4 | 1.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 1.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 1.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 3.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 3.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 0.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 2.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 1.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 1.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 0.8 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 4.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 1.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 2.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 2.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 6.4 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.2 | 0.9 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 8.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 0.7 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 0.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 1.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 1.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 0.6 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 1.9 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 2.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 6.8 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.7 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 1.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.9 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 1.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 1.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.8 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 1.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.9 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 1.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 1.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 1.2 | GO:0033655 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.1 | 6.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 5.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 1.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 2.0 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 2.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 10.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 1.0 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.7 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 1.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.6 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 4.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.0 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.0 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.7 | 8.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.9 | 9.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.8 | 5.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.5 | 4.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.5 | 4.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.4 | 4.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.3 | 2.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.3 | 5.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.2 | 8.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.2 | 5.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.1 | 1.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.1 | 9.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.0 | 4.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.9 | 2.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.9 | 3.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.9 | 2.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.9 | 3.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.8 | 2.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.7 | 1.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.7 | 3.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.7 | 1.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.7 | 2.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 2.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.6 | 3.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.6 | 1.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.6 | 3.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.6 | 3.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.6 | 3.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.6 | 2.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.6 | 1.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.5 | 2.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 6.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 3.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.5 | 1.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 4.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.5 | 4.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 1.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.5 | 1.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 2.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 2.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 2.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 1.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.4 | 9.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 2.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 0.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 3.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.4 | 12.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 0.8 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 1.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 0.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.4 | 1.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 3.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 1.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 1.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 1.5 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.4 | 1.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 4.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 1.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 4.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.3 | 2.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 2.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 1.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 7.4 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 1.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 6.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 1.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 2.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 3.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 1.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 1.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.3 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 1.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 2.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 3.9 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 1.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 1.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 0.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 0.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 2.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.3 | 0.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 0.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 6.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 1.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 4.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 1.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 1.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.2 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.2 | 0.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 1.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 0.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 3.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 0.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 1.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 1.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 0.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 1.2 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 0.6 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 1.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.8 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 1.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 3.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 4.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 2.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 4.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 1.9 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 3.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 1.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 2.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 2.2 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 1.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.5 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 0.5 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.2 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 1.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 3.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 2.0 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 3.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 2.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 0.6 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 2.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 1.5 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 3.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.4 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 2.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.4 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 1.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.5 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 1.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 1.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 1.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 1.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 1.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 2.0 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 2.4 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.1 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 1.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.7 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.1 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
0.1 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 1.9 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 1.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 1.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 1.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 1.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 1.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 0.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 2.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 16.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 4.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 4.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 4.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 15.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 2.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 5.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 3.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 3.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 2.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 8.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 3.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 0.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.5 | 4.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 1.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 8.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 12.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 6.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 16.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 4.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 5.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 6.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 5.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 4.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 5.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 6.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 5.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 7.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 7.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 2.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 1.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 3.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 2.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 3.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 2.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 0.2 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.2 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 2.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 1.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 2.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 2.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 3.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 6.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 2.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 5.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 2.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.7 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 0.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 2.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 2.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |